156 related articles for article (PubMed ID: 22848863)
1. Malignant mixed mullerian tumor: an immunohistochemical study.
Bing Z; Pasha T; Wang LP; Zhang PJ
Patholog Res Int; 2012; 2012():569609. PubMed ID: 22848863
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
4. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
5. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
Cao D; Li J; Guo CC; Allan RW; Humphrey PA
Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
[TBL] [Abstract][Full Text] [Related]
6. Extrauterine pelvic malignant mixed mesodermal tumors. A study of 10 cases with immunohistochemistry.
Deligdisch L; Plaxe S; Cohen CJ
Int J Gynecol Pathol; 1988; 7(4):361-72. PubMed ID: 2466009
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors.
Liu A; Cheng L; Du J; Peng Y; Allan RW; Wei L; Li J; Cao D
Am J Surg Pathol; 2010 May; 34(5):697-706. PubMed ID: 20410807
[TBL] [Abstract][Full Text] [Related]
8. Primary Mediastinal Yolk Sac Tumors: An Immunohistochemical Analysis of 14 Cases.
Weissferdt A; Kalhor N; Rodriguez Canales J; Fujimoto J; Wistuba II; Moran CA
Appl Immunohistochem Mol Morphol; 2019 Feb; 27(2):125-133. PubMed ID: 27643524
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
[TBL] [Abstract][Full Text] [Related]
10. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical profile of malignant mixed müllerian tumor. Overlap with endometrial adenocarcinoma.
Meis JM; Lawrence WD
Am J Clin Pathol; 1990 Jul; 94(1):1-7. PubMed ID: 1694389
[TBL] [Abstract][Full Text] [Related]
12. SALL4 is a useful marker for pediatric yolk sac tumors.
Wu P; Luo R; Sun B; Zhao J; Xu Q; Feng S; Chen X; Wang C
Pediatr Surg Int; 2020 Jun; 36(6):727-734. PubMed ID: 32222813
[TBL] [Abstract][Full Text] [Related]
13. Primary peritoneal malignant mixed Müllerian tumors. A clinicopathologic, immunohistochemical, and genetic study.
Shen DH; Khoo US; Xue WC; Ngan HY; Wang JL; Liu VW; Chan YK; Cheung AN
Cancer; 2001 Mar; 91(5):1052-60. PubMed ID: 11251959
[TBL] [Abstract][Full Text] [Related]
14. Malignant mixed mullerian tumor of the cervix including components of a rhabdomyosarcoma: case report and literature review.
Lee SH; Kim J; Kim JH; Lee KH; Park JS; Hur SY
Eur J Gynaecol Oncol; 2010; 31(4):462-6. PubMed ID: 20882897
[TBL] [Abstract][Full Text] [Related]
15. Malignant mixed Mullerian tumour of the uterus.
Rajshekar SK; Guruprasad B; Shakunthala P; Rathod P; Devi U; Bafna U
Ecancermedicalscience; 2013; 7():302. PubMed ID: 23589731
[TBL] [Abstract][Full Text] [Related]
16. Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor.
Zhang L; Shimizu D; Killeen JL; Honda SA; Lu D; Stanoyevitch A; Lin F; Wang B; Monuki ES; Carbone M
Hum Pathol; 2016 Jul; 53():159-67. PubMed ID: 26980026
[TBL] [Abstract][Full Text] [Related]
17. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
18. Hepatoid Teratoma, Hepatoid Yolk Sac Tumor, and Hepatocellular Carcinoma: A Morphologic and Immunohistochemical Study of 30 Cases.
Al-Obaidy KI; Williamson SR; Shelman N; Idrees MT; Ulbright TM
Am J Surg Pathol; 2021 Jan; 45(1):127-136. PubMed ID: 32991342
[TBL] [Abstract][Full Text] [Related]
19. Multiple pulmonary metastases with halo-sign from malignant mixed Müllerian tumors.
Tian HW; Yang WB; Yang MJ; Liu JY; Zhang JC; Tao XN; Zhou Q
Oncol Lett; 2017 Dec; 14(6):6645-6649. PubMed ID: 29151911
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of P16 and P53 expression in uterine malignant mixed mullerian tumors.
Buza N; Tavassoli FA
Int J Gynecol Pathol; 2009 Nov; 28(6):514-21. PubMed ID: 19851197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
